Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNCL002028

Drug Information
NameOlodaterol
SynonymsBI-1744
CompanyBoehringer Ingelheim Pharmaceuticals Ridgefield, CT
IndicationAsthma
[ICD9: 493   ICD10: J45]
Phase II    
COPD
[ICD9: 490-492, 494-496   ICD10: J40-J44, J47]
Phase III    
Chronic obstructive pulmonary Disease (COPD)Phase III    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C21H26N2O5/c1-21(2,10-13-4-6-15(27-3)7-5-13)22-11-18(25)16-8-1
4(24)9-17-20(16)28-12-19(26)23-17/h4-9,18,22,24-25H,10-12H2,1-3H3
,(H,23,26)/t18-/m0/s1
InChIKeyCOUYJEVMBVSIHV-SFHVURJKSA-N
Canonical SMILESCC(C)(CC1=CC=C(C=C1)OC)NCC(C2=CC(=CC3=C2OCC(=O)N3)O)O    
Isomeric SMILESCC(C)(CC1=CC=C(C=C1)OC)NC[C@@H](C2=CC(=CC3=C2OCC(=O)N3)O)O
FormulaC21H26N2O5
PubChem Compound IDCID 11504295.
SuperDrug ATC IDR03AC19
TargetLong-acting beta2



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543